India, Sept. 1 -- President Donald Trump has announced that nine mid-sized pharmaceutical companies have agreed to lower prescription drug prices for Americans in line with the lowest prices paid by other developed nations.
The nine drug makers are Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB.
The agreements bring the total number of pharmaceutical manufacturers with the most-favored-nation deals to 26, covering 89 percent of the U.S. branded drug market.
The Trump Administration had previously signed agreements with Pfizer, Astra Zeneca, EMD Serono, Eli Lilly, Novo Nordisk, Amgen, Bristol Myers Squibb, Boehringer Ingelheim, Genentech, Gilead Sciences, GSK, Merck, Novarti...